In addition to our in-house development programs, Immunyx is highly interested in collaboration with pharma partners. Numerous drugs targeting neutrophils and the immune microenvironment have failed due to systemic toxicity or poor drug distribution.

Our platform allows partners to use their existing drugs or new pipeline molecules with an enhanced level of accuracy and efficacy by packaging them in our targeted nanoparticles.

By combining tools and technologies we are able to reshape the landscape of drug treatment bringing the patient better results and less side-effects.

To read more about our recent partnership activities click here.

For collaboration inquiries email [email protected].